Skip to NavigationSkip to content

News

0
The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing...
0
To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
0
The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the Academic Health...
0
PrEP drugs – pre-sex drugs that are able to dramatically reduce the chances a person has of contracting HIV – should be made available on the NHS,...

Features

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and...